---
schema_version: "secwatch.filing_event.v1"
accession: "0001750155-25-000077"
form_type: "8-K"
ticker: "CWBHF"
cik: "0001750155"
company_name: "Charlotte's Web Holdings, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:20:46.524582+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Charlotte's Web Q3 revenue $11.5M (-8.6% YoY); net loss $5.9M; targets $9M cost savings in 2026

## Summary
- Revenue $11.5M vs $12.6M in Q3 2024; gross margin 38.9% (down from 53%) due to $0.5M B2B chargeback reserve and in-house manufacturing ramp.
- SG&A fell 23.3% to $9.7M; adjusted EBITDA improved to $(2.1)M from $(3.9)M; cash $9.8M, working capital $25.6M.
- B2B channel restructured: direct sales force cut, $0.5M reserve recorded; management expects margin rebound to ~50% in Q4 2025.
- New Brightside hemp-derived delta-9 gummies launched; CBN Stay Sleep Gummies became second-best-selling gummy; functional mushroom portfolio expanding.
- U.S. Senate CR included hemp THC limit language effective 365 days post-enactment; DeFloria IND Phase 2 trial for ASD cleared; board adds British American Tobacco nominee.

## SEC filing metadata
- accession: 0001750155-25-000077
- form_type: 8-K
- ticker: CWBHF
- cik: 0001750155
- company_name: Charlotte's Web Holdings, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750155/000175015525000077/0001750155-25-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750155/000175015525000077/cweb-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001750155-25-000077
- JSON: https://secwatch.observer/filing/0001750155-25-000077.json
- Plain text: https://secwatch.observer/filing/0001750155-25-000077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.